Exciting News for Patients with Certain Forms of Rectal Cancer and HER-2 Positive Breast Cancer!

Two reports from the June 2022 meeting of the American Society of Clinical Oncology (ASCO) have generated great excitement and reporting by the New York Times and multiple media. The most important cancer meeting of the year was attended by 30,000 oncologists and the attention was overwhelmingly given to the new development in the treatment